Yoann Cazaubon

8PUBLICATIONS
9CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersToxicology (incl. clinical toxicology)Medical infection agents (incl. prions)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 28, 2023
Comparative Evaluation of Four Commercially Available Immunoassays for Therapeutic Drug Monitoring of Infliximab and Adalimumab.

Florian Rissel, Yoann Cazaubon, Syrine Saffar

|Feb 25, 2023
Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses.

Lucas Perez, Philippe Corne, Grégoire Pasquier

|Jan 21, 2023
Development and Validation of a Non-Targeted Screening Method for Most Psychoactive, Analgesic, Anaesthetic, Anti-Diabetic, Anti-Coagulant and Anti-Hypertensive Drugs in Human Whole Blood and Plasma Using High-Resolution Mass Spectrometry.

Catherine Feliu, Celine Konecki, Yoann Cazaubon

|Dec 28, 2021
Quantification of 15 Antibiotics Widely Used in the Critical Care Unit with a LC-MS/MS System: An Easy Method to Perform a Daily Therapeutic Drug Monitoring.

Catherine Feliu, Celine Konecki, Tristan Candau

|Aug 28, 2021
External Evaluation of Population Pharmacokinetic Models and Bayes-Based Dosing of Infliximab.

Celine Konecki, Catherine Feliu, Yoann Cazaubon

|Apr 25, 2020
Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?

Quentin Allard, Zoubir Djerada, Claire Pouplard

Pageof 2

Frequent Collaborators

6 joint publications

Zoubir Djerada

4 joint publications

Catherine Feliu

3 joint publications

Celine Konecki

1 joint publications

Hélène Peyret